Thompson Elizabeth H.Z. sold ACAD
July 30, 2026 · Form 4 insider transaction
Thompson Elizabeth H.Z. sold 16,508 shares of Acadia Pharmaceuticals Inc. at $26.13 per share, a transaction worth $431.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
16,508
Price
$26.13
Total value
$431.4K
InsiderThompson Elizabeth H.Z.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 30, 2026
Filing dateJuly 31, 2026
Shares owned after19,044
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).